PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 104 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $345,000 | +54.0% | 64,469 | +47.5% | 0.12% | +108.3% |
| Q4 2018 | $224,000 | -49.0% | 43,701 | -3.6% | 0.06% | -66.9% |
| Q3 2018 | $439,000 | -5.2% | 45,327 | -0.2% | 0.18% | -22.3% |
| Q2 2018 | $463,000 | +25.8% | 45,427 | +60.2% | 0.23% | +9.9% |
| Q1 2018 | $368,000 | – | 28,356 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $36,172,000 | 26.83% |
| Abingworth LLP | 1,301,413 | $18,103,000 | 18.96% |
| Roumell Asset Management, LLC | 290,136 | $4,036,000 | 9.16% |
| Monashee Investment Management LLC | 100,000 | $1,391,000 | 2.19% |
| BVF INC/IL | 575,000 | $7,998,000 | 1.70% |
| Aisling Capital LLC | 482,680 | $6,714,000 | 1.59% |
| Opaleye Management Inc. | 146,700 | $2,041,000 | 1.36% |
| Broadfin Capital, LLC | 803,332 | $11,174,000 | 1.09% |
| GENERAL AMERICAN INVESTORS CO INC | 477,076 | $6,636,000 | 0.69% |
| Opus Point Partners Management, LLC | 37,665 | $524,000 | 0.51% |